Learn about Pfizer’s decision to discontinue its once-a-day obesity pill due to liver concerns. Discover company’s focus on developing a twice-daily treatment.
Learn about Pfizer’s decision to discontinue its once-a-day obesity pill due to liver concerns. Discover company’s focus on developing a twice-daily treatment.